Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins

被引:25
|
作者
Liu, Yalan [1 ]
Luo, Sukun [1 ,2 ]
He, Siyi [1 ,2 ]
Zhang, Mudan [1 ,2 ]
Wang, Ping [1 ,2 ]
Li, Chang [1 ,2 ]
Huang, Wenjie [1 ]
Hu, Bodan [1 ,2 ]
Griffin, George E. [3 ]
Shattock, Robin J. [4 ]
Hu, Qinxue [1 ,3 ]
机构
[1] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England
[4] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Fac Med, London W2 1PG, England
基金
中国国家自然科学基金;
关键词
HSV-2; Tetherin; Viral release; Viral glycoprotein; HERPES-SIMPLEX-VIRUS; DOWN-REGULATION; HIV-1; RELEASE; CELL-SURFACE; PROTEIN; EXPRESSION; INFECTION; VPU; COMPLEX; TYPE-1;
D O I
10.1016/j.virol.2014.11.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tetherin has been defined as a restriction factor of HIV-1 and several other enveloped viruses. However, the significance of tetherin in viral infection remains to be further addressed. Here, we investigated whether tetherin plays a role in HSV-2 infection. Our study revealed that overexpression of tetherin restricted the release of HSV-2 into the extracellular medium, while knockdown of tetherin by siRNA enhanced its release. We further demonstrated that HSV-2 infection and viral glycoproteins gB, gD, gH and gL but not gM significantly downregulated the endogenous expression of tetherin. Additional study indicated that tetherin likely physically interacted with gB, gD, gH and gL. This is the first time that tetherin has been shown to be counteracted by multiple viral components of a virus. Our findings inform the complexity of HSV-2-host interactions, providing basis for understanding the role of tetherin as a viral restriction factor and the mechanisms underlying viral countermeasures. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 109
页数:14
相关论文
共 50 条
  • [41] Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice
    Krzyzowska, Malgorzata
    Orlowski, Piotr
    Baska, Piotr
    Bodera, Pawel
    Zdanowski, Robert
    Stankiewicz, Wanda
    IMMUNOBIOLOGY, 2014, 219 (12) : 932 - 943
  • [42] Herpes Simplex Virus 2 (HSV-2) Prevents Dendritic Cell Maturation, Induces Apoptosis, and Triggers Release of Proinflammatory Cytokines: Potential Links to HSV-HIV Synergy
    Stefanidou, Martha
    Ramos, Irene
    Casullo, Veronica Mas
    Trepanier, Janie B.
    Rosenbaum, Sara
    Fernandez-Sesma, Ana
    Herold, Betsy C.
    JOURNAL OF VIROLOGY, 2013, 87 (03) : 1443 - 1453
  • [43] Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections
    Tyo, Kevin M.
    Lasnik, Amanda B.
    Zhang, Longyun
    Mahmoud, Mohamed
    Jenson, Alfred B.
    Fuqua, Joshua L.
    Palmer, Kenneth E.
    Steinbach-Rankins, Jill M.
    JOURNAL OF CONTROLLED RELEASE, 2020, 321 : 84 - 99
  • [44] IL-21 has anti-viral effect in innate immunity against vaginal HSV-2 infection in mice
    Kratholm, S.
    Iversen, M. B.
    Holm, C. K.
    IMMUNOLOGY, 2012, 137 : 640 - 640
  • [45] The HSV-2 oncolytic virus Δinduces multiple death and inflammatory programs associated with inhibition of melanoma tumor growth
    Colunga, Aric
    Li, Biquan
    Aurelian, Laure
    CANCER RESEARCH, 2011, 71
  • [46] MICRO-FLUOROMETRIC QUANTITATION OF SIZE, DEOXYRIBONUCLEIC-ACID AND VIRAL ANTIGENIC DETERMINANTS IN CELLS PRODUCTIVELY INFECTED WITH HSV-2
    AURELIAN, L
    TYRER, HW
    GUPTA, PK
    FROST, JK
    ADAMS, LA
    TIFFANY, SM
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1979, 1 (03): : 207 - 216
  • [47] INTRAMUSCULAR VACCINATION OF RABBITS WITH EXPRESSED HSV-2 GLYCOPROTEINS B+D (GB2+GD2) PROTECTS AGAINST DEATH FOLLOWING OCULAR HSV-1 CHALLENGE, BUT NOT FROM EYE DISEASE
    NESBURN, AB
    BURKE, RL
    GHIASI, H
    SLANINA, S
    WECHSLER, SL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1679 - 1679
  • [48] An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
    Egan, Kevin P.
    Hook, Lauren M.
    Naughton, Alexis
    Pardi, Norbert
    Awasthi, Sita
    Cohen, Gary H.
    Weissman, Drew
    Friedman, Harvey M.
    PLOS PATHOGENS, 2020, 16 (07)
  • [49] The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes
    Sperling, Rhoda S.
    Fife, Kenneth H.
    Warren, Terri J.
    Dix, Lynn P.
    Brennan, Clare A.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (03) : 286 - 290
  • [50] HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms
    Kadeppagari, Ravi-Kumar
    Sanchez, Rebecca L.
    Foster, Timothy P.
    VIRUS RESEARCH, 2012, 167 (02) : 273 - 284